BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 6
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16
• 17
• 20
• 21
• 22
• 23
• 24
• 27
• 28
• 29
• 30

• Business

  From $4.5 Billion To Nothing: Forbes Revises Estimated Net Worth Of Theranos Founder Elizabeth Holmes

  June 1, 2016

   · 

  1 min read
• 

  Genetown

  Ionis Pharma’s Pain Propels Alnylam to Gain $1.5 Billion in Market Cap

  June 1, 2016

   · 

  2 min read
• Business

  The Sad And Inspiring Reason This Top Novartis AG Exec Stepped Down

  June 1, 2016

   · 

  1 min read
• 

  Business

  Former Valeant CEO Nabs $9+ Million Severance Deal and Consulting Role

  June 1, 2016

   · 

  3 min read
• 

  Deals

  Activist Investor Carl Icahn’s Big Buy of Allergan Shares Raises Questions of Influence

  June 1, 2016

   · 

  3 min read
• 

  Policy

  All Eyes Turn to Sarepta as BioMarin Shutters Its Kyndrisa Duchenne Program

  June 1, 2016

   · 

  4 min read
• Drug Development

  ChromaDex, Inc. Release: University Researchers Show Vitamin Nicotinamide Riboside Is An Effective Tool For Managing The Negative Effects Of Obesity And Diabetes

  June 1, 2016

   · 

  5 min read
• Business

  Can-Fite BioPharma Reaches Agreement With European Medicines Agency On Pivotal Phase III Clinical Trial With Piclidenoson (CF101) In Rheumatoid Arthritis

  June 1, 2016

   · 

  6 min read
• Drug Development

  ContraVir Initiates Head-To-Head Phase 2a Clinical Study Of CMX157 Vs. Viread For Treating Hepatitis B

  June 1, 2016

   · 

  5 min read
• Business

  InfuSystem Holdings, Inc. Announces Two Long-Term Payor Agreements

  June 1, 2016

   · 

  4 min read